Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 197

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

A simple protein-based surrogate neutralization assay for SARS-CoV-2

Open access
Abe, Kento T., Li, Zhijie, Samson, Reuben, Samavarchi-Tehrani, Payman, Valcourt, Emelissa J., Wood, Heidi, Budylowski, Patrick, Dupuis, Alan P., Girardin, Roxie C., Rathod, Bhavisha, Wang, Jenny H., Barrios-Rodiles, Miriam, Colwill, Karen, McGeer, Allison J., Mubareka, Samira, Gommerman, Jennifer L., Durocher, Yves, Ostrowski, Mario, McDonough, Kathleen A., Drebot, Michael A., Drews, Steven J., Rini, James M., Gingras, Anne-Claude · 2020 · JCI Insight

Abstract

Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mount a humoral immune response to the virus within a few weeks of infection, but the duration of this response and how it correlates with clinical outcomes has not been completely characterized. Of particular importance is the identification of immune correlates of infection that would support public health decision-making on treatment approaches, vaccination strategies, and convalescent plasma therapy. While ELISA-based assays to detect and quantitate antibodies to SARS-CoV-2 in patient samples have been developed, the detection of neutralizing antibodies typically requires more demanding cell-based viral assays. Here, we present a safe and efficient protein-based assay for the detection of serum and plasma antibodies that block the interaction of the SARS-CoV-2 spike protein receptor binding domain (RBD) with its receptor, angiotensin-converting enzyme 2 (ACE2). The assay serves as a surrogate neutralization assay and is performed on the same platform and in parallel with an ELISA for the detection of antibodies against the RBD, enabling a direct comparison. The results obtained with our assay correlate with those of 2 viral-based assays, a plaque reduction neutralization test (PRNT) that uses live SARS-CoV-2 virus and a spike pseudotyped viral vector-based assay.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.142362

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 197

Metadata

Authors
Abe, K. T., Li, Z., Samson, R., Samavarchi-Tehrani, P., Valcourt, E. J., Wood, H., Budylowski, P., Dupuis, A. P., Girardin, R. C., Rathod, B., Wang, J. H., Barrios-Rodiles, M., Colwill, K., McGeer, A. J., Mubareka, S., Gommerman, J. L., Durocher, Y., Ostrowski, M., McDonough, K. A., Drebot, M. A., Drews, S. J., Rini, J. M., & Gingras, A.-C.
Venue
JCI Insight
Published
2020-10-02
Volume
5
Issue
19
ISSN
2379-3708 (ISSN-L)
OpenAlex
W3082734312
Cited by
197
References
13
FWCI
4.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A simple protein-based surrogate neutralization assay for SARS-CoV-2. https://app.cochat.ai/papers/10.1172/jci.insight.142362
The paper
Abe, K. T., Li, Z., Samson, R., Samavarchi-Tehrani, P., Valcourt, E. J., Wood, H., Budylowski, P., Dupuis, A. P., Girardin, R. C., Rathod, B., Wang, J. H., Barrios-Rodiles, M., Colwill, K., McGeer, A. J., Mubareka, S., Gommerman, J. L., Durocher, Y., Ostrowski, M., McDonough, K. A., . . . Gingras, A.-C. (2020). A simple protein-based surrogate neutralization assay for SARS-CoV-2. JCI Insight. https://doi.org/10.1172/jci.insight.142362

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.